Bard© Modified OnFlex ™ Mesh was specifically designed to fit the inguinal anatomy during preperitoneal placement. It offers extended medial and inferior coverage for direct and femoral hernia spaces.
Bard© Modified OnFlex ™ Mesh was specifically designed to fit the inguinal anatomy during preperitoneal placement. It offers extended medial and inferior coverage for direct and femoral hernia spaces.
1. Brown C, Finch J. Which mesh for hernia repair? Annals of The Royal College of Surgeons of England 2010;92(4):272-278.
* Observed in preclinical model, which may not correlate to performance in humans.
Indications
The Modified Onflex™ Mesh is indicated for use in the reinforcement of soft tissue where weakness exists, such as in the repair of inguinal hernias.
Contraindications
Use of this device is contraindicated for infants, children, or pregnant women, whereby future growth will be compromised by use of such mesh material. Literature reports that there is a possibility for adhesion formation when polypropylene is placed in direct contact with the bowel or viscera.
Warnings
The use of any synthetic mesh or patch in a contaminated or infected wound can lead to fistula.
If unused mesh has been in contact with instruments or supplies used on a patient or contaminated with body fluids, discard mesh with care to prevent risk of transmission of viral infections.
To prevent recurrences when repairing hernias, the mesh should be large enough to provide sufficient overlap beyond the margins of the defect. If fixation is used, careful attention to mesh fixation placement and spacing will help prevent excessive tension or gap formation between the mesh and fascial tissue.
To avoid injury, careful attention is required if fixating the mesh in the presence of nerves, vessels, or spermatic cord structures. The mesh is supplied sterile. Inspect the packaging to be sure it is intact and undamaged prior to use. This device is for single use only. Do not resterilize or reuse any portion of the Modified Onflex Mesh.
Excess positioning strap material above the fixation point must be cut off at the level of the fascia and discarded to eliminate excess material from remaining in the body.
Precautions
Please read all instructions prior to use. Only physicians qualified in the appropriate surgical techniques should use this prosthesis.
Care should be taken not to cut or nick the SorbaFlex™ PDO monofilament.
If fixation is used, care should be taken to ensure that the mesh is adequately fixated. If necessary, additional fasteners and/or sutures should be used.
Adverse Reactions
Possible complications may include, but are not limited to, seroma, adhesion, hematoma, pain, infection, inflammation, extrusion, erosion, migration, fistula formation and recurrence of the hernia or soft tissue defect. If the SorbaFlex™ PDO monofilament is cut or damaged, additional complications may include, but are not limited to, bowel or skin perforation and infection.
GTIN - Case
00801741095399
1
Quantity
1/cs.
Dimensions
Medium with pocket, strap & onlay 3.4" x 5.6" (8.6cm x 14.2cm)
GTIN - Case | 00801741095399 | 1 |
Quantity | 1/cs. |
Dimensions | Medium with pocket, strap & onlay 3.4" x 5.6" (8.6cm x 14.2cm) |
Our collection of literature on industries and on our offerings gives you information you can use to continue striving for excellence.
We support the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Find our training resources to help improve your clinical practices as part of our goal of advancing the world of health.
We promote clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.
To better facilitate our investigation, please include the following information in your reporting: